The store will not work correctly when cookies are disabled.
N-[[5-(2-thienyl)-1H-pyrazol-3-yl]methyl]-2-(trifluoromethoxy)benzamide
ID: ALA5087460
Chembl Id: CHEMBL5087460
PubChem CID: 156574629
Max Phase: Preclinical
Molecular Formula: C16H12F3N3O2S
Molecular Weight: 367.35
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NCc1cc(-c2cccs2)[nH]n1)c1ccccc1OC(F)(F)F
Standard InChI: InChI=1S/C16H12F3N3O2S/c17-16(18,19)24-13-5-2-1-4-11(13)15(23)20-9-10-8-12(22-21-10)14-6-3-7-25-14/h1-8H,9H2,(H,20,23)(H,21,22)
Standard InChI Key: OOVLVXYPFKZAMP-UHFFFAOYSA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 367.35 | Molecular Weight (Monoisotopic): 367.0602 | AlogP: 3.97 | #Rotatable Bonds: 5 |
Polar Surface Area: 67.01 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.59 | CX Basic pKa: 1.70 | CX LogP: 3.93 | CX LogD: 3.93 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.72 | Np Likeness Score: -2.17 |
References
1. (2021) Ube2k modulators and methods for their use, |